134 related articles for article (PubMed ID: 37839777)
21. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor.
Lee IJ; Kim SC; Kim HS; Bang D; Yang WI; Jung WH; Chi HS
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):294-7. PubMed ID: 10025851
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic pemphigus caused by pre-existing stroma-rich variant of Castleman disease: from a pathologist's point of view.
Gwiti P; Melegh Z; Johnston S; Sutak J
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975839
[TBL] [Abstract][Full Text] [Related]
23. A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman's disease.
Fang Y; Zhao L; Yan F; Cui X; Xia Y; Duren A
Med Oncol; 2010 Sep; 27(3):907-11. PubMed ID: 19763912
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China.
Wang J; Zhu X; Li R; Tu P; Wang R; Zhang L; Li T; Chen X; Wang A; Yang S; Wu Y; Yang H; Ji S
Arch Dermatol; 2005 Oct; 141(10):1285-93. PubMed ID: 16230567
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic pemphigus associated with Castleman's tumour.
Caneppele S; Picart N; Bayle-Lebey P; Paul J; Irsutti M; Oksman F; Joly P; Bazex J
Clin Exp Dermatol; 2000 May; 25(3):219-21. PubMed ID: 10844500
[TBL] [Abstract][Full Text] [Related]
26. Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus.
Liu Q; Bu DF; Li D; Zhu XJ
Br J Dermatol; 2008 Mar; 158(3):587-91. PubMed ID: 18070207
[TBL] [Abstract][Full Text] [Related]
27. Paraneoplastic Pemphigus Mimicking Pemphigus Vulgaris Associated With Castleman Disease.
Grigore M; Costache M; Simionescu O
Cureus; 2023 Mar; 15(3):e36114. PubMed ID: 37065416
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic pemphigus.
Yong AA; Tey HL
Australas J Dermatol; 2013 Nov; 54(4):241-50. PubMed ID: 22759072
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour.
Wolff H; Kunte C; Messer G; Rappersberger K; Held E; Löhrs U; Plewig G; Meurer M
Br J Dermatol; 1999 Feb; 140(2):313-6. PubMed ID: 10233229
[TBL] [Abstract][Full Text] [Related]
30. Unicentric Castleman Disease.
Wong RSM
Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and management of Castleman disease.
Soumerai JD; Sohani AR; Abramson JS
Cancer Control; 2014 Oct; 21(4):266-78. PubMed ID: 25310208
[TBL] [Abstract][Full Text] [Related]
32. Castleman disease: CT and MR imaging features of a retroperitoneal location in association with paraneoplastic pemphigus.
Irsutti M; Paul JL; Selves J; Railhac JJ
Eur Radiol; 1999; 9(6):1219-21. PubMed ID: 10415265
[TBL] [Abstract][Full Text] [Related]
33. Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome.
Chen YH; Zastrow DB; Metcalfe RD; Gartner L; Krause F; Morton CJ; Marwaha S; Fresard L; Huang Y; Zhao C; McCormack C; Bick D; Worthey EA; Eng CM; Gold J; Undiagnosed Diseases Network ; Montgomery SB; Fisher PG; Ashley EA; Wheeler MT; Parker MW; Shanmugasundaram V; Putoczki TL; Schmidt-Arras D; Laurence A; Bernstein JA; Griffin MDW; Uhlig HH
J Allergy Clin Immunol; 2021 Aug; 148(2):585-598. PubMed ID: 33771552
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic pemphigus in children and adolescents.
Mimouni D; Anhalt GJ; Lazarova Z; Aho S; Kazerounian S; Kouba DJ; Mascaro JM; Nousari HC
Br J Dermatol; 2002 Oct; 147(4):725-32. PubMed ID: 12366419
[TBL] [Abstract][Full Text] [Related]
36. [Surgical treatment and prognosis analysis of localized retroperitoneal Castleman disease: a study of 20 cases].
Tang JQ; Yang YM; Xiong Y; Wan YL; Zhu XJ
Zhonghua Wai Ke Za Zhi; 2009 Nov; 47(22):1685-8. PubMed ID: 20137716
[TBL] [Abstract][Full Text] [Related]
37. Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.
Hu S; Li Z; Wang H; Chen L; Ma Y; Zhu X; Li J; Dong R; Yao W; Dong C; Zhang H; Li K; Dong K; Zhai X
Eur J Pediatr; 2023 Dec; 182(12):5519-5530. PubMed ID: 37782352
[TBL] [Abstract][Full Text] [Related]
38. Systemic lupus erythematosus combined with Castleman disease and secondary paraneoplastic pemphigus: a case report.
Ma X; Li J; Fan L; Jiang H; Shi G; Ge D; Shi X
Pediatr Rheumatol Online J; 2023 Oct; 21(1):126. PubMed ID: 37858241
[TBL] [Abstract][Full Text] [Related]
39. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
[TBL] [Abstract][Full Text] [Related]
40. [A case of retroperitoneal Castleman's disease with paraneoplastic pemphigus].
Zhang Z; Zhou M; Guo J; Feng T; Li X; Chen H; Li J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 May; 41(5):548-52. PubMed ID: 27269932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
